Items Tagged ‘Dana Farber Cancer Center’

July 9, 2018

Aromasin plus Ovarian Suppression Yields Benefit in High-risk Premenopausal Breast Cancer Patients


Premenopausal women with hormone receptor-positive, HER2-negative breast cancer and a high risk of recurrence who are treated with an aromatase inhibitor plus ovarian function suppression may gain 10 to 15 percent improvement in freedom from distant recurrence at eight years, according to a new clinical trial analysis reported at the annual meeting of the American […]

View full entry

Tags: Breast Cancer, Dana Farber Cancer Center, Harvard, News, premenopausal breast cancer treatment